Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsNadine Housri, MD
Associate Professor AdjunctDownloadHi-Res Photo
About
Copy Link
Titles
Associate Professor Adjunct
Biography
Dr. Housri’s clinical focus is in thoracic oncology and stereotactic radiosurgery.
Last Updated on November 16, 2023.
Appointments
Therapeutic Radiology
Associate Professor AdjunctPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Yale School of Medicine (2015)
- Resident
- Rutgers Robert Wood Johnson Medical School (2014)
- MD
- University of Miami Miller School of Medicine (2009)
Research
Copy Link
Overview
Medical Research Interests
Lung
ORCID
0000-0001-7447-4223
Research at a Glance
Yale Co-Authors
Frequent collaborators of Nadine Housri's published research.
Publications Timeline
A big-picture view of Nadine Housri's research output by year.
Henry S. Park, MD, MPH
Christin A. Knowlton, MD, MA
Thomas Hayman, MD, PhD
Allison Campbell, MD, PhD
Amit Mahajan, MD, MBBS
Anne Chiang, MD, PhD
22Publications
554Citations
Publications
2026
Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State
Ninia JG, Verma N, Long JB, Laird JH, Hicks DF, Hayman TJ, Knowlton CA, Campbell AM, Housri N, Peters GW, Al Feghali KA, de Jong D, Chiang AC, Park HS. Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State. Clinical Lung Cancer 2026, 27 DOI: 10.1016/j.cllc.2026.03.009.Peer-Reviewed Original Research
2024
Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy
Verma N, Laird J, Moore N, Hayman T, Housri N, Peters G, Knowlton C, Jairam V, Campbell A, Park H. Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy. Advances In Radiation Oncology 2024, 9: 101500. PMID: 38699671, PMCID: PMC11063223, DOI: 10.1016/j.adro.2024.101500.Peer-Reviewed Original ResearchCitationsAltmetricConceptsLocal recurrence-free survivalNon-lung primaryAssociated with higher local recurrence-free survivalProgression-free survivalBiologically Effective DoseLocal controlRadioresistant metastasesOverall survivalPulmonary metastasesPrimary cancerColorectal carcinomaAssociated with superior local controlMultivariate analysisPatients treated with radiotherapyRisk of local recurrenceMedian follow-up timeMultivariable Cox proportional hazards regressionInferior local controlMedian total doseSuperior local controlAssociated with decreased riskImpact of histologyMetastasis-free survivalRecurrence-free survivalLocal failure
2023
Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy
Sasse A, Oh P, Saeed N, Yang D, Hayman T, Knowlton C, Peters G, Campbell A, Laird J, Housri N, Park H. Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy. Practical Radiation Oncology 2023, 14: e97-e104. PMID: 37984711, DOI: 10.1016/j.prro.2023.11.006.Peer-Reviewed Original ResearchCitationsAltmetricConceptsMean lung doseHypofractionated radiation therapyRisk of gradeRadiation pneumonitisLung V20Lung V5Dose-volume predictorsDosimetric risk factorsLogistic regression analysisGrade 5 casesSingle healthcare systemPrimary endpointDose regimensMultivariable analysisLung doseThoracic tumorsDosimetric variablesRisk factorsPneumonitisRadiation therapyCommon treatmentClinical practicePatientsSignificant associationPotential predictors
2020
Provider Engagement in Radiation Oncology Data Science: Workshop Report.
Jain AK, Aneja S, Fuller CD, Dicker AP, Chung C, Kim E, Kirby JS, Quon H, Lam CJK, Louv WC, Ahern C, Xiao Y, McNutt TR, Housri N, Ennis RD, Kang J, Tang Y, Higley H, Berny-Lang MA, Camphausen KA. Provider Engagement in Radiation Oncology Data Science: Workshop Report. JCO Clinical Cancer Informatics 2020, 4: 700-710. PMID: 32755458, PMCID: PMC7469584, DOI: 10.1200/cci.20.00051.Peer-Reviewed Original ResearchCitationsAltmetricMeSH KeywordsUsing a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic.
Bejjani A, Burt L, Washington C, Terao M, Housri S, Housri N. Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic. JCO Clinical Cancer Informatics 2020, 4: 794-798. PMID: 32897736, PMCID: PMC7529517, DOI: 10.1200/cci.20.00073.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsGynecologic oncologyPediatric oncologyActive disease sitesCOVID-19 pandemicOncology patientsMedical oncologyClinical managementBreast cancerOncology expertsCare resourcesInitial experienceDisease sitesDisease typeOncologyWorldwide pandemicOncologistsRadiation oncologyHealth careCOVID-19Peer-reviewed informationSubstantial numberPandemicTotal numberPatientsCancer
2019
Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trials
Yu J, Singh C, Bindra R, Contessa J, Husain Z, Hansen J, Park H, Roberts K, Bond J, Tien C, Guo F, Colaco R, Housri N, Magnuson W, Mahajan A, Omay S, Chiang V. Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trials. Journal Of Radiation Oncology 2019, 8: 39-46. DOI: 10.1007/s13566-018-0370-7.Peer-Reviewed Original ResearchAltmetricConceptsYale-New Haven HospitalPhase II studyBrain metastasesClinical trialsII studyKnife radiosurgeryLocal controlPre-defined primary endpointWhole-brain radiation treatmentFuture prospective clinical trialsEvaluable brain metastasesSymptomatic radiation necrosisMedian patient ageLocal control ratePhase 2 studyGood local controlProspective clinical trialsNumber of metastasesLarge clinical trialsProportional hazards regressionFuture clinical trialsGamma knife radiosurgeryImportant clinical variablesStandard clinical practiceNew Haven Hospital
2017
Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice
Rosenberg SA, Baschnagel AM, Bagley SJ, Housri N. Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice. Current Oncology Reports 2017, 19: 5. PMID: 28168606, DOI: 10.1007/s11912-017-0563-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsAltmetricMeSH Keywords and ConceptsConceptsStereotactic body radiotherapyNon-small cell lung cancer (NSCLC) treatmentCell lung cancer treatmentLung cancer treatmentNational clinical trialEvidence-based treatmentsEvidence-based medicineTranslating EvidenceCommunity oncologistsBody radiotherapyLung cancerClinical trialsPreclinical discoveryClinical practiceCommunity settingsCancer treatmentOncologistsCommunity practiceTreatmentMedicineImmunotherapyNSCLCInternet-based resourcesRadiotherapyCancer
2015
Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials
Housri N, Khan AJ, Taunk N, Goyal S, Nelson CJ, Ferro A, Haffty BG. Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials. The Breast Journal 2015, 21: 387-394. PMID: 25919123, DOI: 10.1111/tbj.12419.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBreast cancer patientsNon-white womenCancer patientsClinical trialsWhite womenRacial disparitiesRadiation oncology clinical trialsBreast cancer clinical trialsRetrospective cohort studyClinico-pathologic factorsLymph node positivityUse of chemotherapyClinical trial enrollmentOncology clinical trialsUse of brachytherapyBreast radiotherapy trialsCancer clinical trialsPaucity of dataCohort studyNode positivityPatient demographicsReceptor statusTrial enrollmentTumor characteristicsDisease stage
2014
Electronic Medical Record: A Balancing Act of Patient Safety Privacy Health Care Delivery
Gummadi S, Housri N, Zimmers TA, Koniaris LG. Electronic Medical Record: A Balancing Act of Patient Safety Privacy Health Care Delivery. The American Journal Of The Medical Sciences 2014, 348: 238-243. PMID: 24879530, DOI: 10.1097/maj.0000000000000287.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricIs There a Role for Postmastectomy Radiation Therapy After Complete Pathologic Response to Neoadjuvant Chemotherapy?
Housri N, Haffty B. Is There a Role for Postmastectomy Radiation Therapy After Complete Pathologic Response to Neoadjuvant Chemotherapy? Current Breast Cancer Reports 2014, 6: 38-44. DOI: 10.1007/s12609-013-0134-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPathologic complete responsePostmastectomy radiationNeoadjuvant chemotherapySmall primary tumorsAdvanced breast cancerComplete pathologic responseNode-negative diseasePostmastectomy radiation therapyInitial clinical stageTime of mastectomyMulti-institutional trialPatterns of practiceAdvanced diseasePathologic responseComplete responseClinical stagePrimary tumorBreast cancerRadiation therapyRadiation indicationsLower riskPatientsRadiation oncologistsRetrospective dataChemotherapy
News
Copy Link
Get In Touch
Copy Link